Global Animal Antimicrobials and Antibiotics Market, By Product Type (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Aminoglycosides, Lincosamides), Mode of Delivery (Premixes, Oral Powder, Injection), Animal (Food-Producing Animals, Companion Animals), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Animal Antimicrobials and Antibiotics Market
The animal antimicrobials and antibiotics market is expected to witness market growth at a rate of approximately 4.50% in the forecast period of 2021 to 2028 and is expected to reach USD 3.20 billion by 2028. Data Bridge Market Research report on animal antimicrobials and antibiotics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increasing livestock population is escalating the growth of animal antimicrobials and antibiotics market.
Antibiotics and antimicrobials are used for the purpose of enhancing the health of livestock and companion animals and also, increasing the productivity of food-producing animals. Several authorities worldwide have implemented stringent regulations to approve animal pharmaceutical products in order to ensure that these products do not exhibit negative effects on animal health.
The rise in the demand for livestock products across the globe acts as one of the major factors driving the growth of animal antimicrobials and antibiotics market. The wide availability of various kinds of animal antimicrobials and antibiotics types such as quinolones, penicillin, cephalosporin, sulphonamides, macrolides, tetracycline and amino glycosides and high demand for penicillin based antibiotics accelerate the animal antimicrobials and antibiotics market growth. The rise in the prevalence of zoonotic diseases globally and growing initiatives concerning animal health and welfare further influence the animal antimicrobials and antibiotics market. Additionally, rise in demand for animal protein products, improvement in animal feed, expansion of animal meat industry, growing animal health expenditure and increase in animal disease outbreaks positively affect the animal antimicrobials and antibiotics market. Furthermore, rise in demand for pet insurance and emerging economies extend profitable opportunities to the animal antimicrobials and antibiotics market players in the forecast period of 2021 to 2028.
On the other hand, the routine prophylactic use of antibiotics being replaced by good husbandry, probiotics and hygiene practices and low number of new antibiotics are the factors expected to obstruct the animal antimicrobials and antibiotics market growth. The growing resistance to antimicrobials and antibiotics and stringent approval process for antimicrobials and antibiotics are projected to challenge the animal antimicrobials and antibiotics market in the forecast period of 2021-2028.
This animal antimicrobials and antibiotics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on animal antimicrobials and antibiotics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Animal Antimicrobials and Antibiotics Market Scope and Market Size
The animal antimicrobials and antibiotics market is segmented on the basis of product type, mode of delivery and animal. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the animal antimicrobials and antibiotics market is segmented into tetracycline, penicillin, sulfonamide, macrolide, cephalosporin, fluoroquinolone, aminoglycosides and lincosamides.
- On the basis of mode of delivery, the animal antimicrobials and antibiotics market is segmented into premixes, oral powder and injection.
- On the basis of animal, the animal antimicrobials and antibiotics market is segmented into food-producing animals and companion animals. Food-producing animals are further segmented into cattle, pigs, poultry, sheep and goats and other food-producing animals. Companion animals are further segmented into dogs, cats, horses and other companion animals.
Global Animal Antimicrobials and Antibiotics Market Country Level Analysis
The animal antimicrobials and antibiotics market is analyzed and market size, volume information is provided by country, product type, mode of delivery and animal as referenced above.
The countries covered in the global animal antimicrobials and antibiotics market report are the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the animal antimicrobials and antibiotics market due to the increase in the region’s animal population, growth in pet insurance, rise in demand for animal-derived food products and surge in animal health expenditure. Asia-Pacific is expected to witness the highest CAGR during the forecast period of 2021 to 2028 because of the increasing animal population and rising demand for animal-derived food products in the region.
The country section of the animal antimicrobials and antibiotics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Animal Antimicrobials and Antibiotics Market Share Analysis
The animal antimicrobials and antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to animal antimicrobials and antibiotics market.
The major players covered in the animal antimicrobials and antibiotics market report are Zoetis, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva, Eli Lilly and Company, Bayer AG, Dechra Pharmaceuticals PLC, Virbac, Vetoquinol S.A, Sanofi, Bioniche Animal Health, Elanco, Fort Dodge Animal Health, Endovac Animal Health, ECO Animal Health Group plc, Indian Immunologicals Ltd., Ashish Life Science, Lutim Pharma Private Limited among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-